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T he pharyngeal mucosal space is a common pri-mary region for both head and neck squamous 
cell carcinoma (SCC) and extranodal malignant lym-
phoma [1].  These 2 tumors tend to occur at the same 
regions,  such as the tonsil and tongue base,  and show 
similar imaging findings [1].  The high density of lym-
phoid tissue in the tonsils predisposes these regions to 
the development of malignant lymphoma [2].  A large 
malignant lymphoma of the oropharynx may infiltrate 
the deep structures and mimic advanced SCC.  Since the 
treatments of malignant lymphoma and SCC differ con-
siderably,  their pretreatment imaging evaluation is of 
critical importance.  
Positron emission tomography (PET) with 2-deoxy-
2-18F-fluoro-D-glucose (18F-FDG) is a useful functional 
tool for the diagnosis and surveillance of SCC and 
malignant lymphoma in the head and neck region [3].  
The most commonly used PET semiquantitative param-
eter is the maximum standardized uptake value 
(SUVmax).  Kato et al.  found no significant difference 
in the SUVmax between SCC and non-Hodgkin’s lym-
phoma (NHL) in the naso- or oropharynx [2].  Both 
SCC and malignant lymphoma in the head and neck 
region show intense 18F-FDG uptake,  making it difficult 
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We assessed the role of 18F-FDG PET/CT texture indices for the differentiation of squamous cell carcinoma 
(SCC) and non-Hodgkin’s lymphoma (NHL) in the oropharynx.  18F-FDG PET/CT data for 27 patients with SCC 
and 25 patients with NHL in the oropharynx were investigated.  The maximum standardized uptake value 
(SUVmax),  metabolic tumor volume (MTV),  total lesion glycolysis (TLG),  and six texture indices (homogene-
ity,  entropy,  short-run emphasis,  long-run emphasis,  low gray-level zone emphasis [LGZE],  and high gray-
level zone emphasis [HGZE]) were derived from PET images.  PET/CT parameters of the SCC patients were 
compared with those of the NHL patients.  The diagnostic accuracy of the indices for differentiating SCC from 
NHL was calculated by a receiver operating characteristic curve analysis.  18F-FDG uptake in the oropharynx was 
observed in all of the patients.  The SUVmax,  MTV,  and TLG did not differ significantly between the SCC and 
NHL groups,  but two of the six texture indices (LGZE [p= 0.004] and HGZE [p= 0.03]) showed significant dif-
ferences between the groups.  LGZE was the best discriminative index for the differentiation of SCC and NHL 
(55.6% sensitivity,  88.0% specificity).  The LGZE and HGZE texture indices derived from 18F-FDG PET/CT 
images may be useful in differentiating SCC and NHL in the oropharynx.
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to differentiate them by only 18F-FDG SUV analysis.  
Accordingly,  increasing attention is being turned to 
measurements of tumor heterogeneity [4].  Although 
several investigators have focused on the textural fea-
tures of 18F-FDG PET in patients with head and neck 
SCC,  these features are not sufficient [5-8].
To the best of our knowledge,  no published report 
has focused on the use of PET texture analysis to differ-
entiate between SCC and malignant lymphoma of the 
oropharynx.  Here,  we assessed the usefulness of 18F-
FDG PET/CT texture indices for this purpose.
Patients and Methods
Patients. We retrospectively reviewed the 18F-
FDG PET/CT findings obtained in 60 patients with 
SCC (n = 35) or NHL (n = 25) of the oropharynx before 
therapy who were examined during the period from 
March 2013 to April 2020 at our hospital.  Eight of the 
patients with SCC were excluded because they did not 
exhibit sufficient 18F-FDG tumor uptake for the textural 
analysis.  Finally,  the cases of 27 patients with SCC and 
25 with NHL in the oropharynx were available for 18F-
FDG PET/CT studies.  Their clinical data are summa-
rized in Table 1.
This study was approved by our institutional ethics 
review committee,  and the requirement for informed 
consent was waived due to its retrospective nature.
Radiotracer synthesis and PET/CT imaging.  
18F-FDG was produced using an automated synthesis 
system with an HM-18 cyclotron (QUPID; Sumitomo 
Heavy Industries,  Tokyo).
All acquisitions were performed using a Biograph 
mCT 64-slice PET/CT scanner (Siemens Medical 
Solutions USA,  Knoxville,  TN,  USA),  which has a 
21.6-cm axial field of view.
The patients were instructed to fast for at least 5 h 
before the 18F-FDG administration.  A normal glucose 
level in the peripheral blood was confirmed before the 
injection.  PET emission scanning (2 min per bed posi-
tion) was performed 90 min after an intravenous injec-
tion of 18F-FDG (3.7 MBq/kg) from the midcranium to 
the proximal thighs,  and co-registered with an unen-
hanced CT examination of the same region (Quality 
Reference mAs: 100 mAs [using CARE Dose4D];  
reconstructed slice thickness: 5 mm).  The PET data 
were reconstructed with a baseline ordered-subset 
expectation maximization (OSEM) algorithm,  incor-
porating correction with a point-spread function and 
time-of-flight model (two iterations,  21 subsets).  A 
Gaussian filter with a full-width at half-maximum of 
5 mm was used as a post-smoothing filter.
Image analyses. A board-certified nuclear medi-
cine physician (K.M.) performed the PET/CT image 
analyses.  The texture and SUV parameter extraction of 
the oropharyngeal tumors was performed using the 
LIFEx package [9].  After the volume of interest (VOI) 
of the oropharyngeal primary tumor was selected using 
a threshold of 40% of the SUVmax,  the metabolic 
tumor volume (MTV) was calculated.  In the same VOI,  
the SUVmax was calculated using the following formu-
la: SUV = cdc/(di/w),  where cdc is the decay-corrected 
tracer tissue concentration (Bq/g),  di is the injected dose 
(Bq),  and w is the patient’s body weight (g).  Total lesion 
glycolysis (TLG) was defined as the product of the MTV 
and the mean SUV.
Texture indices were deduced from three texture 
matrices—the co-occurrence matrix,  the gray-level run 
length matrix,  and the gray-level zone length matrix—
according to the report of Orlhac et al.  [10].  Six texture 
indices were calculated: homogeneity,  entropy,  short-
run emphasis (SRE),  long-run emphasis (LRE),  low 
gray-level zone emphasis (LGZE),  and high gray-level 
zone emphasis (HGZE).  These indices have been found 
to be the most robust indices with respect to the seg-
mentation method in each texture correlation group 
[11].
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Age (years) Mean 67.1 74.4
Range 44-87 44-98
Sex (n) Male 21 15
Female  6 10
Lesion site (n) Tonsil 22 20
Base of tongue  3 5
Soft palate  1
Posterior pharyngeal wall  1
Histological subtype (n)
Well differentiated SCC  8
Moderately differentiated SCC 12
Poorly differentiated SCC  7
Diffuse large B cell lymphoma 23
Follicular lymphoma 1
Mantle cell lymphoma 1
SCC,  squamous cell carcinoma; NHL,  non-Hodgkinʼs lymphoma.
Statistical analyses. All statistical analyses were 
performed using the SPSS Statistics software package 
ver. 26 (IBM).  Data were analyzed for statistical signif-
icance using the Mann-Whitney U-test.  Differences in 
PET/CT parameters among histological subtypes in the 
patients with SCCs were compared with an analysis of 
variance (ANOVA).  Receiver operating curve (ROC) 
analyses providing area-under-the-curve (AUC) values 
were performed to evaluate the diagnostic ability of the 
18F-FDG PET/CT parameters to differentiate between 
SCC and NHL of the oropharynx.  Differences were 
considered statistically significant at p-values < 0.05.
Results
Oropharyngeal primary tumors were detected in all 
SCC and NHL patients on 18F-FDG PET/CT images.  
Typical PET/CT images from SCC and NHL patients 
are shown in Fig. 1 and 2,  respectively.
Table 2 summarizes the results of the PET/CT 
parameters.  No significant differences were noted in the 
SUVmax,  MTV,  or TLG values between the SCC and 
NHL groups.  Two of the 6 texture indices,  i.e.,  the 
LGZE (p = 0.004) and the HGZE (p = 0.03),  showed sig-
nificant differences between the SCC and NHL groups.  
The values of SUVmax,  MTV,  TLG,  homogeneity,  
entropy,  SRE,  LRE,  LGZE,  and HGZE in the single 
case of follicular lymphoma were 12.30,  4.56,  32.64,  
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Table 2　 18F-FDG PET/CT findings of the patients with oropharyngeal SCC and NHL
18F-FDG PET/CT SCC (n=27) NHL (n=25)
P value
parameter Mean SD Mean SD
SUVmax 18.29 8.84 20.84 6.58 0.06
MTV 13.80 11.93 12.89 13.41 0.41
TLG 152.81 128.47 176.66 194.05 0.91
Homogeneity 0.304 0.163 0.272 0.121 0.21
Entropy 2.028 0.531 2.024 0.360 0.63
SRE 0.931 0.098 0.942 0.061 0.41
LRE 1.633 1.297 1.441 0.642 0.39
LGZE 0.00179 0.00124 0.00090 0.00500 0.004
HGZE 1255.04 794.92 1710.26 724.02 0.03
SCC,  squamous cell carcinoma; NHL,  non-Hodgkinʼs lymphoma; SUVmax,  maximum standardized uptake value; MTV,  metabolic tumor 
volume; TLG,  total lesion glycolysis; SRE,  short-run emphasis; LRE,  long-run emphasis; LGZE,  low gray-level zone emphasis; HGZE,  
high gray-level zone emphasis.
Fig. 1　 PET/CT images from a 79-year-old male diagnosed with 
well-differentiated squamous cell carcinoma in the left palatine 
tonsil.  The transverse 18F-FDG PET image (a) and fused PET/CT 
image (b) show intense uptake in the tumor: SUVmax=14.37,  
MTV=6.94,  TLG=61.30,  homogeneity=0.219,  entropy=2.135,  
SRE=0.975,  LRE=1.111,  LGZE=0.00155,  and HGZE=816.78.
Fig. 2　 PET/CT images from a 77-year-old male diagnosed with 
diffuse large B-cell lymphoma in the left palatine tonsil.  The 
transverse 18F-FDG PET image (a) and fused PET/CT image (b) 
show intense uptake in the tumor: SUVmax=33.52,  MTV=3.95,  
TLG=84.02,  homogeneity=0.512,  entropy=1.161,  SRE=0.802,  
LRE=2.359,  LGZE=0.00038,  and HGZE=2758.68.
0.236,  1.936,  0.974,  1.106,  0.00215,  and 611.74,  
respectively.  The corresponding values in the single case 
of mantle cell lymphoma were 14.69,  9.82,  87.26,  
0.230,  2.269,  0.976,  1.109,  0.00142,  and 903.02,  
respectively.  When these two cases were excluded from 
the analysis,  the SUVmax (p = 0.04),  LGZE (p = 0.002),  
and HGZE (p= 0.02) were significantly different between 
the SCC and NHL groups.
Table 3 summarizes the results of the PET/CT 
parameters of the patients with SCCs according to the 
histological subtype.  No significant difference in any of 
the PET/CT parameters was noted among the histolog-
ical subtypes.
The LGZE was the best discriminative index for the 
differentiation of SCC and NHL: AUC of 0.735,  cutoff 
value of 0.00142,  55.6% sensitivity and 88.0% specific-
ity.  The discriminative index for the differentiation of 
SCC and NHL by the HGZE was as follows: AUC of 
0.686,  cutoff value of 895.54,  51.9% sensitivity and 
88.0% specificity.
Additional findings. In the patients with SCC,  
18F-FDG PET/CT showed 24 nodal sites (all cervical) 
and two extranodal sites (all bone) suggestive of metas-
tases.  In the patients with NHL,  18F-FDG PET/CT 
showed 28 nodal sites suggestive of involvement (21 
cervical,  3 mediastinal,  2 retroperitoneal,  and 2 ingui-
nal).
Discussion
SCC and malignant lymphoma are the most com-
mon primary tumors occurring in the oropharynx,  and 
their radiologic imaging characteristics are sometimes 
impossible to distinguish.  The present study is the first 
to focus on the differentiation of these tumors using an 
18F-FDG PET/CT texture analysis.  The results of our 
analyses demonstrated that two texture indices that use 
the gray-level zone length matrix may be of value in the 
differentiation of SCC and NHL of the oropharynx.  
The 18F-FDG SUVmax of renal lymphoma was 
reported by Nicolau et al.  to be higher compared to that 
of renal cell carcinoma [12].  Ou et al.  similarly docu-
mented higher 18F-FDG SUVmax values of breast lym-
phoma compared to those of breast carcinoma [13].  In 
the present study,  although the SUVmax values of the 
NHLs tended to be higher than those of the SCCs,  the 
difference was not significant.  Kato et al.  also demon-
strated no significant difference in the SUVmax between 
SCCs and NHLs in the naso- or oropharynx [2].  A 
similar result obtained by Cho et al.  indicated that the 
SUVmax value was not conclusive in distinguishing 
between nasopharyngeal lymphoma and nasopharyn-
geal carcinoma [14].  However,  although we observed 
no significant difference in 18F-FDG SUVmax values 
between carcinoma and lymphoma in the head and neck 
region,  additional large studies will be needed to con-
firm these findings.
Lv et al.  reported that 18F-FDG PET texture param-
eters outperformed the MTV in the differentiation of 
nasopharyngeal carcinoma and chronic nasopharyngi-
tis [15].  Chen et al.  reported that 18F-FDG PET/CT 
texture parameters could differentiate benign from 
malignant solitary pulmonary nodules [16].  Most of the 
previous reports about texture features focused on the 
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Table 3　 18F-FDG PET/CT findings of the patients with oropharyngeal SCC according to the histological subtype
18F-FDG PET/CT Well (n=8) Moderately (n=12) Poorly (n=7)
parameter Mean SD Mean SD Mean SD
SUVmax 18.74 10.63 19.66 9.79 15.43 4.19
MTV 13.65 10.68 11.86 10.57 17.31 16.04
TLG 134.09 79.28 152.15 146.62 175.34 154.00
Homogeneity 0.334 0.207 0.316 0.175 0.247 0.056
Entropy 1.941 0.598 1.974 0.568 2.222 0.394
SRE 0.912 0.131 0.924 0.104 0.966 0.017
LRE 1.886 1.796 1.704 1.321 1.220 0.176
LGZE 0.00174 0.00120 0.00166 0.00133 0.00206 0.00126
HGZE 1179.42 839.29 1346.16 907.41 1185.27 613.97
SCC,  squamous cell carcinoma; SUVmax,  maximum standardized uptake value; MTV,  metabolic tumor volume; TLG,  total lesion glycol-
ysis; SRE,  short-run emphasis; LRE,  long-run emphasis; LGZE,  low gray-level zone emphasis; HGZE,  high gray-level zone emphasis;  
Well,  well differentiated SCC; Moderately,  moderately differentiated SCC; Poorly,  poorly differentiated SCC.
differentiation of benign and malignant lesions.  Several 
researchers have evaluated the feasibility of using 18F-
FDG PET/CT texture parameters to predict cancer 
subtypes by analyzing the ability of these parameters to 
differentiate primary and metastatic lung tumors [17] or 
adenocarcinoma and SCC of the lung [18].  The great 
potential of texture parameters for the differentiation of 
lesions,  not only between benign and malignant lesions 
but also among malignancy subtypes,  is now being 
more widely recognized.  However,  the ability of 18F-
FDG texture features to reliably predict malignant lym-
phoma and carcinoma remains unclear.
To the best of our knowledge,  the present study is 
the first to perform an 18F-FDG PET/CT texture analysis 
between SCC and NHL of the oropharynx.  Orlhac et al.  
observed that healthy tissue showed higher homogene-
ity,  lower entropy,  higher LGZE values,  and lower 
HGZE values compared to tumor tissue [19].  Ou et al.  
confirmed that the HGZE values of breast lymphoma 
were higher than those of breast carcinoma [13],  which 
is consistent with our present findings.  They suggested 
that the differences in tumor cell proliferation may be a 
possible explanation for the different 18F-FDG uptake 
between breast lymphoma and carcinoma [13].  Xu and 
colleagues also showed that 18F-FDG PET texture 
parameters were more effective than SUV parameters in 
differentiating hepatocellular carcinoma from hepatic 
lymphoma [20].
Although the textural indices have been reported as 
potentially useful,  the consistency of published results 
is difficult to assess for several reasons: the name given 
to a textural index does not always correspond to the 
same definition; many texture indices have been stud-
ied and the methods used to calculate them have not 
always been identical; and the optimal threshold for the 
tumor volume for a texture analysis is different in each 
study.  Due to the still limited experience of 18F-FDG 
PET texture analyses in distinguishing malignant lym-
phoma and carcinoma,  additional studies in this area 
are still needed.
Chan et al.  showed that heterogeneity on 18F-FDG 
PET/CT was prognostically superior to traditional SUV 
parameters in patients with oro- or hypopharyngeal 
SCC [5].  Chen et al.  also demonstrated that 18F-FDG 
heterogeneity indices were more informative than clas-
sical SUV parameters for the prediction of prognosis in 
patients with pharyngeal cancer [6].  Such findings are 
attributable to the inability of classical PET parameters 
such as SUV to delineate tumor heterogeneity,  which 
has been explained by a number of underlying factors,  
including cellular proliferation,  cellularity,  angiogene-
sis,  necrosis,  and vascularization [21].  However,  the 
exact biological correlates of these PET heterogeneity 
parameters are not yet clear.
Limitations of the present study include its small 
sample size and retrospective design.  Most of the NHLs 
in the present study were diffuse large B-cell lymphoma 
(DLBCL),  accounting for 92% of the total.  This may 
have introduced bias in comparisons of SCC and 
DLBCL of the oropharynx.  Additional large prospec-
tive studies are needed to test and expand the present 
results.
Chan et al.  found the combination of 18F-FDG PET/
CT heterogeneity parameters and dynamic contrast-en-
hanced MRI parameters to be useful in the prediction of 
patient prognosis in pharyngeal cancer [5].  It is antici-
pated that advances in hardware such as simultaneous 
PET/MRI will help to further facilitate imaging 
research in analyses of tumor heterogeneity.  Few tumor 
heterogeneity studies have been undertaken using 
newer radiopharmaceuticals other than 18F-FDG.  
Further studies are needed to investigate texture fea-
tures to elucidate their potential clinical value.
In conclusion,  although this preliminary study was 
conducted in a small patient population,  its results 
clearly suggested that 18F-FDG PET/CT texture indices 
using the gray-level zone length matrix may be useful in 
differentiating SCC and NHL in the oropharynx.
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